Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-04
2007-12-04
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S108000
Reexamination Certificate
active
11206233
ABSTRACT:
The present invention concerns a method of treatment or prevention of myocardial ischemia-reperfusion injury by diagnosing that a person is in need of treatment or prevention of myocardial ischemia-reperfusion injury and administering a therapeutically effective amount of a ligand which modulates NF-kB transcription factor by interaction with estrogen receptor ER-α, estrogen receptor ER-β, or both ER-α and ER-β estrogen receptors with a substantial absence of creatine kinase stimulation. In certain preferred embodiments, the administration is substantially without uterotropic activity.
REFERENCES:
patent: 5877169 (1999-03-01), Simpkins
patent: 6326365 (2001-12-01), Simpkins et al.
patent: 6339078 (2002-01-01), Simpkins et al.
patent: 6350739 (2002-02-01), Simpkins et al.
patent: 6894061 (2005-05-01), Molinari et al.
patent: 2005/0113405 (2005-05-01), Harnish et al.
patent: 2005/0119276 (2005-06-01), Harnish et al.
patent: 2005/0119324 (2005-06-01), Harnish et al.
Delyani et al. J. Mol. Cell Cardiol. 28, 1001-1008 (1996).
Boden E. P. et al., “Proton-Transfer Steps in Steglich Esterification: A Very Practical New Method for Macrolactonization,”J. Org. Chem, 1985, 50, 2394-2395.
Delyani, J. A. et al., “Protection from myocardial reperfusion injury by acute administration of 17β-estradiol,”J. Mol. Cell Cardiol.1996, 28,1001-1008.
Hale, S.L. et al., “β-estradiol, but not α-estradiol, reduces myocardial necrosis in rabbits after ischemia and reperfusion,”Am. Heart J.1996,132, 258-262.
Huang J. et al., “Efficient Cross-Coupling of Aryl Chlorides with Aryl Grignard Reagents (Kumada Reaction) Mediated by a Palladium/Imidazolium Chloride System,”J. Am. Chem Soc., 1999, 121, 9889-9890.
Hulley, S. et. al., “Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart disease in Postmenopausal Women,”J. Am. Med. Assoc., 1998, 280(7), 605-613.
Kim, Y. D. et al., “17β-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion,”Circulation1996, 94(11), 2901-2908.
Krishnan, R. et al., “Reactions of Hydroxybenzophenone with Hydrazines,”J. Heterocycl. Chem, 1988, 25, 447-452.
Li, H. Y. et al., “Enhanced responses to 17β-estradiol in rat hearts treated with isoproterenol: Involvement of a cyclic AMP-dependent pathway,” 2000,J. Pharmacol. Exp. Ther.293(2), 592-598.
Lucchesi, B. R., “Myocardial reperfusion injury—Role of free radicals and mediators of inflammation,” inHeart Physiology and Pathophysiology, 4th ed. Chapter 65, pp. 1181-1220, Academic Press (2001).
March's Adv. Org. Chem, 5thed, 16: 1183, Wiley Interscience, 2001.
Miyaura, N. et al., “Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds,”Chem Rev., 1995, 95, 2457-2483.
Node, K. et al., “Roles of NO and Ca2+-activated K+channels in coronary vasodilation induced by 17β-estradiol in ischemic heart failure,”FASEB J.1997, 11, 793-799.
Pfeffer, M. A. et al., “Myocardial infarct No one size fits all,”Circulation, 2002, 105, 2577-2579.
Robertson et.al., “Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors,”J. Med. Chem., 1990, 33, 3176-3181.
Rodriguez, M. J. et al., “The Synthesis of Water Soluble Prodrugs Analogs of Echinocandin B,”Bioorg. Med. Chem. Lett., 1999, 9, 1863-1868.
Chadwick Christopher Cyril
Harnish Douglas Carl
Chu Yong
Klein Daniel
Wyeth
LandOfFree
Method of treating myocardial ischemia-reperfusion injury... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating myocardial ischemia-reperfusion injury..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating myocardial ischemia-reperfusion injury... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3892536